quinazolines has been researched along with Chronic Illness in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 44 (55.00) | 18.7374 |
1990's | 7 (8.75) | 18.2507 |
2000's | 22 (27.50) | 29.6817 |
2010's | 6 (7.50) | 24.3611 |
2020's | 1 (1.25) | 2.80 |
Authors | Studies |
---|---|
Hong, S; Wiley, JW; Zheng, G; Zhu, S; Zong, Y | 1 |
Koskinen, PK; Palin, N; Rintala, JM; Rintala, SE; Savikko, J; von Willebrand, E | 1 |
Gong, GQ; Jiang, ML; Li, YZ; Wang, XH; Yan, W; Zhang, ZX | 1 |
Akay, OM; Andıç, N; Bolaman, AZ; Kadıköylü, VG; Ünübol, M; Yağcı, E; Yavaşoğlu, İ | 1 |
Tan, Q; Zhang, J | 1 |
Camidge, DR; Erickson, TM; Koeppe, JR; Miller, YE; Stuart, RW | 1 |
D'adda, M; Drera, M; Ferrari, S; Micheletti, M; Rossi, G | 1 |
Alexander, RB; Anderson, RU; Berger, R; Chuai, S; Krieger, JN; Kusek, JW; Landis, JR; Liong, ML; Litwin, MS; McNaughton-Collins, M; Nadler, R; Nickel, JC; Nyberg, LM; O'Leary, M; Pontari, M; Schaeffer, AJ; Shoskes, DA; White, PC; Zeitlin, S | 1 |
de Stricker, K; Hasselbalch, HC; Larsen, TS; Møller, MB; Pallisgaard, N | 1 |
Gisslinger, H; Krumpl, G; Linkesch, W; Petrides, PE; Schüller, A; Steurer, M; Widmann, R | 1 |
Wagenlehner, FM; Weidner, W | 1 |
Chadjichristos, C; Chatziantoniou, C; Dussaule, JC; Flamant, M; François, H; Guerrot, D; Helle, F; Jouzel, C; Placier, S | 1 |
Kattan, MW; Nickel, JC; Shoskes, DA | 1 |
Fu, H; Marelli-Berg, FM; McCormack, AM; Okkenhaug, K; Rose, ML; Sarathchandra, P; Ying, H | 1 |
Kvasnicka, HM; Schmitt-Gräff, A; Thiele, J | 1 |
Beaton, HG; Boughton-Smith, N; Cook, TR; Cooper, SL; Fraser-Rae, L; Hallam, K; Hamley, P; McInally, T; Nicholls, DJ; Pimm, AD; Tinker, AC; Wallace, AV | 1 |
Albitar, M; Colburn, DE; Cortes, JE; Giles, FJ; Kantarjian, HM; O'Brien, SM; Tsimberidou, AM; Verstovsek, S; Welch, MA | 1 |
Alas, P; Helström, PJ; Mehik, A; Nickel, JC; Sarpola, A | 1 |
Brunnbauer, K; Fuchs, N; Kvasnicka, HM; Schmitt-Graeff, A; Thiele, J; Volkwein, N | 1 |
Birgegård, G; Björkholm, M; Kutti, J; Lärfars, G; Löfvenberg, E; Markevärn, B; Mauritzson, N; Merup, M; Palmblad, J; Samuelsson, J; Westin, J | 1 |
Clausen, NT; Hansen, PB; Hasselbalch, HC; Jensen, BA; Mourits-Andersen, T; Nielsen, OJ; Penninga, E | 1 |
Bevan, S; Christiansen, M; Copp, P; Culshaw, AJ; Davis, A; Davis, C; Dyson, A; Dziadulewicz, EK; Edwards, L; Eggelte, H; Fox, A; Gentry, C; Groarke, A; Hallett, A; Hart, TW; Hughes, GA; Knights, S; Kotsonis, P; Lee, W; Lyothier, I; McBryde, A; McIntyre, P; Paloumbis, G; Panesar, M; Patel, S; Seiler, MP; Yaqoob, M; Zimmermann, K | 1 |
Jantunen, E; Kuittinen, T; Nousiainen, T; Penttilä, K | 1 |
Cabello, P; Cesar, JM; Ferro, T; Navarro, JL | 1 |
Lowe, FC; Santillo, VM | 1 |
Herzog, M; Hosemann, W; Kaftan, H; Lempas, K; Vogelgesang, S | 1 |
Cervantes, F | 1 |
Nickel, JC | 1 |
Fishman, AP; Janicki, JS; Kinasewitz, GT; Reichek, N; Weber, KT; West, JS | 1 |
Awan, NA; Lui, HK; Mason, DT | 1 |
Froer, KL; Hall, D; Rudolph, W | 1 |
Kaftańska, A; Paradowski, S; Szmydt, W | 1 |
Hagel, KJ; Netz, H; Rautenburg, HW; Röhner, G | 1 |
Guzińska, B; Nartowicz, E | 1 |
Koyanagi, T; Okamura, K; Takamatsu, T | 1 |
Coxon, R; Sharpe, DN | 1 |
Elenkova, A; Kaloianova, A; Nikolov, G; Terzieva, L; Tomov, I | 2 |
Bassand, JP; Becque, O; Bernard, Y; Berthout, P; Magnin, D; Maurat, JP; Vial, Y | 1 |
Rutishauser, W | 1 |
Clarke, GM; Cope, GD; Hockings, BE; Taylor, RR | 1 |
Forfang, K; Ihlen, H; Kjekshus, J; Thaulow, E | 1 |
Fukaya, T; Hayashi, H; Matsui, E; Niwa, T; Oba, M; Okubo, M; Sassa, H | 1 |
Henry, DP; Stein, L; Weinberger, MH | 1 |
Kukes, VG; Rumiantsev, AS; Shagako, EV; Shustikova, GB; Zisel'man, SB | 1 |
Bertel, O; Bühler, FR; Burkart, F | 1 |
Awan, NA; DeMaria, AN; Lee, G; Mason, DT | 1 |
Awan, NA; Mason, DT | 1 |
Boch, H; Kuhn, H; Lösse, B | 1 |
Silke, B; Taylor, SH | 1 |
Fukami, K; Fuseno, H; Haze, K; Hiramori, K; Honda, T; Ikeda, M; Saito, M; Tanaka, N; Umemoto, M | 1 |
Bussmann, WD | 1 |
Cabaniss, CD | 1 |
Bleifeld, W; Hanrath, P; Kuck, KH; Mathey, D; Zehnke, A | 1 |
Hołub, A; Robak, T; Treliński, J | 1 |
Fukuchi, Y; Hanasato, N; Kira, S; Nishino, M; Oka, M; Yamaguchi, K | 1 |
Sréter, L | 1 |
Anyukhovsky, EP; Danilo, P; Gainullin, RZ; Kirchengast, M; Rosen, MR; Sosunov, EA | 1 |
Feldman, EL; Greene, DA; Stevens, MJ | 1 |
Oka, M | 1 |
Ghimicescu, R | 1 |
Aronow, WS; Danahy, DT | 1 |
Elkayam, U; Frishman, WH; Lejemtel, TH; Mathur, M; Ribner, HS; Sonnenblick, EH; Strom, J | 1 |
Arnold, SB; Baughman, RA; Benet, LZ; Chatterjee, K; Parmley, WW; Ports, TA; Williams, RL | 1 |
Arnold, S; Brundage, B; Chatterjee, K; Parmley, W; Ports, TA | 1 |
Conti, CR; Iacona, M; Mehta, J; Pepine, CJ | 1 |
Awan, NA; Mason, DT; Miller, MP; Miller, RR; Specht, K; Vera, Z | 1 |
Gorlin, R; Herman, MV; Meller, J; Packer, M | 1 |
Braunwald, E | 1 |
Awan, NA; DeMaria, AN; Mason, DT; Maxwell, KS; Miller, RR; Neumann, A | 1 |
Hosoda, S; Kaneko, N; Kawagoe, Y; Kimata, S; Kimura, H; Konno, K; Miki, N; Nagashima, H; Sumiyoshi, T | 1 |
Ambrosioni, E; Borghi, C; Boschi, S; Costa, FV; Mussi, A | 1 |
Guba, GP; Tarasiuk, VK; Timko, NA | 1 |
Hasegawa, K; Inoue, S; Kawahara, Y; Nezuo, S; Sawayama, T; Tadaoka, S | 1 |
Fukuta, S; Itagaki, T; Kusukawa, R; Toma, Y; Umemoto, S; Yamakawa, K; Yoshinaga, T | 1 |
Champoud, O; Cribier, A; Letac, B | 1 |
Bussmann, WD; Kaltenbach, M; Nadj, M; Reifart, N; Schmidt-Moritz, AD | 1 |
Bayliss, J; Canepa-Anson, R; Norell, MS; Poole-Wilson, P; Reid, C; Sutton, G | 1 |
Ishii, M; Ito, I; Ogawa, T; Sekiguchi, T; Sugishita, Y | 1 |
Hillenbrand, P; Sherlock, S | 1 |
6 review(s) available for quinazolines and Chronic Illness
Article | Year |
---|---|
Evodiamine and Its Role in Chronic Diseases.
Topics: Analgesics; Animals; Anti-Allergic Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Obesity Agents; Antineoplastic Agents, Phytogenic; Chronic Disease; Disease Models, Animal; Evodia; Humans; Molecular Structure; Phytotherapy; Plants, Medicinal; Quinazolines; Signal Transduction; Structure-Activity Relationship | 2016 |
The management of chronic prostatitis in men with HIV.
Topics: Adrenergic alpha-Antagonists; Algorithms; Antiretroviral Therapy, Highly Active; Chronic Disease; Comorbidity; Cystoscopy; HIV Infections; Humans; Male; Pelvic Pain; Prostatitis; Quercetin; Quinazolines; Sulfonamides; Tamsulosin; Urodynamics | 2006 |
Myelofibrosis: biology and treatment options.
Topics: Benzamides; Chronic Disease; Darbepoetin alfa; Erythropoietin; Hematopoietic Stem Cell Transplantation; Humans; Hydroxyurea; Imatinib Mesylate; Interferon-alpha; Piperazines; Primary Myelofibrosis; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Recombinant Proteins; Splenectomy; Thalidomide | 2007 |
Role of alpha1-blockers in chronic prostatitis syndromes.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Ejaculation; Humans; Male; Pelvic Pain; Prostatism; Prostatitis; Quality of Life; Quinazolines; Randomized Controlled Trials as Topic; Secondary Prevention; Syndrome | 2008 |
[Anagrelide--new antiplatelet drug].
Topics: Animals; Chronic Disease; Humans; Megakaryocytes; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines | 1994 |
Diabetic neuropathy: scope of the syndrome.
Topics: Aldehyde Reductase; Animals; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Foot; Diabetic Neuropathies; Disease Progression; Enzyme Inhibitors; Humans; Neural Conduction; Prevalence; Quinazolines; Syndrome | 1999 |
16 trial(s) available for quinazolines and Chronic Illness
Article | Year |
---|---|
Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Humans; Male; Middle Aged; Pelvic Pain; Prostatitis; Quinazolines; Severity of Illness Index; Treatment Failure; Young Adult | 2008 |
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Area Under Curve; Chromatography, High Pressure Liquid; Chronic Disease; Cross-Over Studies; Double-Blind Method; Female; Humans; Longitudinal Studies; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Quinazolines; Randomized Controlled Trials as Topic; Solubility; Therapeutic Equivalency; Thrombocytosis; Young Adult | 2009 |
Alfuzosin treatment for chronic prostatitis/chronic pelvic pain syndrome: a prospective, randomized, double-blind, placebo-controlled, pilot study.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Chronic Disease; Double-Blind Method; Humans; Male; Middle Aged; Pain Measurement; Pelvic Pain; Pilot Projects; Prospective Studies; Prostate-Specific Antigen; Prostatitis; Quinazolines; Treatment Outcome; Urodynamics | 2003 |
Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.
Topics: Adult; Aged; Chronic Disease; Diarrhea; Dose-Response Relationship, Drug; Female; Headache; Heart Rate; Humans; Male; Middle Aged; Myeloproliferative Disorders; Nausea; Patient Compliance; Patient Dropouts; Platelet Aggregation Inhibitors; Prospective Studies; Quinazolines; Thrombocytosis | 2004 |
Anagrelide treatment in 52 patients with chronic myeloproliferative diseases.
Topics: Adult; Aged; Anemia; Chronic Disease; Female; Hemorrhage; Humans; Male; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Quinazolines; Retrospective Studies; Thrombocytosis; Thromboembolism; Treatment Outcome | 2004 |
[The use of anagrelide to treat thrombocytosis in connection with the chronic myeloproliferative disease].
Topics: Administration, Oral; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finland; Follow-Up Studies; Humans; Male; Myeloproliferative Disorders; Prospective Studies; Quinazolines; Risk Assessment; Thrombocytosis; Treatment Outcome | 2006 |
Long-term vasodilator therapy with trimazosin in chronic cardiac failure.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Carbon Dioxide; Chronic Disease; Clinical Trials as Topic; Echocardiography; Female; Heart Failure; Humans; Long-Term Care; Male; Middle Aged; Oxygen; Oxygen Consumption; Physical Exertion; Piperazines; Placebos; Pulmonary Ventilation; Quinazolines; Random Allocation; Vasodilator Agents | 1980 |
[Clinical and polycardiographic evaluation of prazosin in the treatment of chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Female; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Myocardial Contraction; Prazosin; Quinazolines | 1984 |
Prazosin and captopril in chronic heart failure: comparison of acute haemodynamic and hormonal effects.
Topics: Aged; Aldosterone; Blood Pressure; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Pulmonary Wedge Pressure; Quinazolines; Random Allocation; Renin; Stroke Volume; Vascular Resistance | 1982 |
[Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Clinical Trials as Topic; Erythrityl Tetranitrate; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1982 |
Prazosin in the treatment of severe chronic congestive cardiac failure.
Topics: Adult; Aged; Chronic Disease; Echocardiography; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure.
Topics: Aged; Chronic Disease; Clinical Trials as Topic; Drug Tolerance; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Nitroprusside; Norepinephrine; Prazosin; Quinazolines; Renin | 1981 |
[Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
Topics: Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Erythrityl Tetranitrate; Female; Heart Failure; Hemodynamics; Humans; Male; Placebos; Prazosin; Quinazolines | 1981 |
Efficacy of trimazosin and prazosin therapy on cardiac and exercise performance in outpatients with chronic congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Physical Exertion; Piperazines; Placebos; Prazosin; Quinazolines; Vasodilator Agents | 1978 |
[Lack of symptomatic and long-term hemodynamic effects of prazosin in chronic heart failure. Double-blind, randomized study over one year].
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Heart Valve Prosthesis; Hemodynamics; Humans; Long-Term Care; Middle Aged; Postoperative Complications; Prazosin; Quinazolines | 1985 |
Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin.
Topics: Aged; Captopril; Chronic Disease; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Female; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prazosin; Proline; Quinazolines; Renin-Angiotensin System; Time Factors | 1985 |
58 other study(ies) available for quinazolines and Chronic Illness
Article | Year |
---|---|
Histone H3K9 methylation regulates chronic stress and IL-6-induced colon epithelial permeability and visceral pain.
Topics: Animals; Caco-2 Cells; Chronic Disease; Colon; Epithelium; Histones; Humans; Interleukin-6; Male; Methylation; Permeability; Quinazolines; Rats; Rats, Sprague-Dawley; Stress, Psychological; Visceral Pain | 2020 |
Epidermal growth factor inhibition, a novel pathway to prevent chronic allograft injury.
Topics: Animals; Aorta; Chronic Disease; Epidermal Growth Factor; Erlotinib Hydrochloride; Graft Rejection; Immunohistochemistry; Kidney; Kidney Transplantation; Male; Quinazolines; Rats; Rats, Wistar; Transplantation, Homologous | 2014 |
Antidepressant-like effect of evodiamine on chronic unpredictable mild stress rats.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chronic Disease; Corticosterone; Hippocampus; Male; Norepinephrine; Phosphorylation; Quinazolines; Rats, Sprague-Dawley; Receptor, trkB; RNA, Messenger; Serotonin; Stress, Psychological | 2015 |
Clinical Features of 294 Turkish Patients with Chronic Myeloproliferative Neoplasms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chronic Disease; Female; Hemorrhage; Humans; Hydroxyurea; Janus Kinase 2; Male; Middle Aged; Mutation; Myeloproliferative Disorders; Quinazolines; Retrospective Studies; Risk Factors; Turkey; Venous Thromboembolism; Young Adult | 2016 |
Bronchioloalveolar carcinoma presenting as chronic progressive pulmonary infiltrates in a woman with HIV: a diagnosis worth making.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Chronic Disease; Diagnosis, Differential; ErbB Receptors; Erlotinib Hydrochloride; Female; HIV; HIV Infections; Humans; Lung Diseases, Interstitial; Middle Aged; Mutation; Prognosis; Protein Kinase Inhibitors; Quinazolines | 2008 |
The combined use of hydroxyurea and anagrelide allows satisfactory hematologic control in patients with chronic myeloproliferative disorders and thrombocytosis: a report on 13 patients with poor tolerance to hydroxyurea monotherapy.
Topics: Adult; Aged; Blood Platelets; Chronic Disease; Drug Therapy, Combination; Drug Tolerance; Female; Hemoglobins; Humans; Hydroxyurea; Male; Middle Aged; Myeloproliferative Disorders; Quinazolines; Retrospective Studies; Thrombocytosis | 2008 |
Limited efficacy of hydroxyurea in lowering of the JAK2 V617F allele burden.
Topics: Alleles; Chronic Disease; Female; Humans; Hydroxyurea; Janus Kinase 2; Male; Mutation; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Polymerase Chain Reaction; Prospective Studies; Quinazolines | 2009 |
Prostatitis: no benefit of alpha-blockers for chronic prostatitis.
Topics: Adrenergic alpha-Antagonists; Chronic Disease; Humans; Male; Prostatitis; Quinazolines; Randomized Controlled Trials as Topic | 2009 |
Improvement of renal hemodynamics during hypertension-induced chronic renal disease: role of EGF receptor antagonism.
Topics: Animals; Arterioles; Blood Pressure; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; ErbB Receptors; Gefitinib; Hypertension; Kidney; Kidney Diseases; Male; NG-Nitroarginine Methyl Ester; Quinazolines; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction | 2009 |
Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Benzhydryl Compounds; Chronic Disease; Cohort Studies; Cresols; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Muscarinic Antagonists; Pain Measurement; Pelvic Pain; Phenotype; Phenylpropanolamine; Probability; Prospective Studies; Prostatitis; Quinazolines; Risk Assessment; Severity of Illness Index; Tolterodine Tartrate; Treatment Outcome; Young Adult | 2010 |
Genetic or pharmaceutical blockade of phosphoinositide 3-kinase p110δ prevents chronic rejection of heart allografts.
Topics: Adenine; Animals; Cells, Cultured; Chronic Disease; Class Ia Phosphatidylinositol 3-Kinase; Female; Flow Cytometry; Graft Rejection; H-Y Antigen; Heart Transplantation; Humans; Immune Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Phosphoinositide-3 Kinase Inhibitors; Quinazolines; Skin Transplantation; T-Lymphocytes; Transplantation, Homologous | 2012 |
[Anagrelide-induced changes of megakaryopoiesis during therapy of chronic myeloproliferative disorders with thrombocythemia].
Topics: Blood Platelets; Chronic Disease; Fibrinolytic Agents; Humans; Megakaryocytes; Myeloproliferative Disorders; Platelet Aggregation Inhibitors; Platelet Count; Proliferating Cell Nuclear Antigen; Quinazolines; Reference Values; Retrospective Studies; Thrombocytosis; Thrombopoiesis | 2002 |
1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Topics: Acute Disease; Administration, Oral; Amines; Animals; Arthritis, Experimental; Cell Line; Chronic Disease; Enzyme Inhibitors; Injections, Intravenous; Isoenzymes; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Quinazolines; Rats; Spiro Compounds; Structure-Activity Relationship | 2003 |
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Chronic Disease; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fibrinolytic Agents; Humans; Imatinib Mesylate; Male; Medical Records Systems, Computerized; Middle Aged; Myeloproliferative Disorders; Piperazines; Pyrimidines; Quinazolines; Retrospective Studies; Survival Analysis | 2003 |
Anagrelide-induced bone marrow changes during therapy of chronic myeloproliferative disorders with thrombocytosis. an immunohistochemical and morphometric study of sequential trephine biopsies.
Topics: Adult; Aged; Biopsy; Blood Platelets; Bone Marrow; Chronic Disease; Drug Evaluation; Humans; Immunohistochemistry; Middle Aged; Myeloproliferative Disorders; Platelet Count; Quinazolines; Retrospective Studies; Thrombocytosis | 2003 |
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic pain.
Topics: Animals; Blood-Brain Barrier; Caco-2 Cells; Cell Membrane Permeability; CHO Cells; Chronic Disease; Cricetinae; Cricetulus; Disease Models, Animal; Humans; In Vitro Techniques; Mice; Micronucleus Tests; Microsomes, Liver; Pain; Quinazolines; Rats; Solubility; Structure-Activity Relationship; TRPV Cation Channels | 2006 |
Emergence of chronic myelogenous leukemia in a patient with primary thrombocythemia and absence of BCR/ABL rearrangement.
Topics: Aged; Antineoplastic Agents; Benzamides; Blood Platelets; Bone Marrow Cells; Cells, Cultured; Chromosomes, Human, Pair 22; Chromosomes, Human, Pair 9; Chronic Disease; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Fusion Proteins, bcr-abl; Humans; Hydroxyurea; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocytes; Piperazines; Pyrimidines; Quinazolines; Thrombocythemia, Essential; Time Factors; Translocation, Genetic; Treatment Outcome | 2006 |
Inhibition of epidermal growth factor receptor by erlotinib: wound healing of experimental tympanic membrane perforations.
Topics: Animals; Chronic Disease; ErbB Receptors; Erlotinib Hydrochloride; Protein Kinase Inhibitors; Quinazolines; Rats; Tympanic Membrane Perforation; Wound Healing | 2007 |
Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
Topics: Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Receptors, Adrenergic, alpha; Water-Electrolyte Balance | 1983 |
[Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
Topics: Adult; Aged; Captopril; Chronic Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Proline; Quinazolines | 1983 |
Prazosin for refractory cardiac failure in children.
Topics: Adolescent; Child; Child, Preschool; Chronic Disease; Heart Failure; Humans; Infant; Male; Prazosin; Quinazolines | 1984 |
[Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
Topics: Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Heart Function Tests; Humans; Male; Prazosin; Quinazolines; Vasodilator Agents | 1983 |
[Management of chronic spinal cord injury patients with prazosin].
Topics: Adult; Chronic Disease; Female; Humans; Male; Middle Aged; Prazosin; Quinazolines; Spinal Cord Injuries; Urination Disorders; Urodynamics | 1983 |
[Hemodynamic effects of prazosin in chronic congestive heart failure].
Topics: Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1980 |
A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Topics: Chronic Disease; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines; Spironolactone; Time Factors | 1983 |
Loss of prazosin effect in severe chronic CHF.
Topics: Adult; Aged; Bed Rest; Chronic Disease; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
Topics: Administration, Oral; Aged; Blood Pressure; Chronic Disease; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Renin; Vascular Resistance | 1980 |
[Use of the new hypotensive agent Minipress (prazosin hydrochloride].
Topics: Adult; Antihypertensive Agents; Chronic Disease; Drug Evaluation; Female; Hemodynamics; Humans; Hypertension; Male; Middle Aged; Prazosin; Quinazolines; Time Factors | 1982 |
Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure.
Topics: Aged; Chronic Disease; Dizziness; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Stroke Volume; Vascular Resistance; Vasodilator Agents | 1981 |
Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
Topics: Administration, Oral; Ambulatory Care; Chronic Disease; Drug Tolerance; Forearm; Heart Failure; Hemodynamics; Humans; Plethysmography, Impedance; Prazosin; Quinazolines; Regional Blood Flow; Vascular Resistance | 1981 |
Oral vasodilator therapy with prazosin in severe congestive heart failure.
Topics: Acute Disease; Administration, Oral; Ambulatory Care; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1981 |
[Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
Topics: Adult; Chronic Disease; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
Pharmacokinetic and haemodynamic studies with prazosin in chronic heart failure.
Topics: Aged; Blood Pressure; Chronic Disease; Coronary Disease; Electrocardiography; Exercise Test; Female; Humans; Male; Middle Aged; Posture; Prazosin; Pulmonary Artery; Quinazolines | 1981 |
[The effects of prazosin in patients with chronic refractory heart failure-acute hemodynamic effects of oral prazosin and long-term therapy (author's transl)].
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines | 1981 |
[Acute and chronic treatment of chronic cardiac insufficiency with nitrates or prazosin respectively].
Topics: Acute Disease; Chronic Disease; Heart Failure; Humans; Nitrates; Prazosin; Quinazolines | 1981 |
Vasodilator therapy of chronic congestive heart failure.
Topics: Ambulatory Care; Chronic Disease; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Quinazolines | 1980 |
[Prazosin long-term treatment in severe chronic cardiac failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Digitalis Glycosides; Diuretics; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Prazosin; Pulmonary Artery; Quinazolines | 1980 |
[E 4021, a cGMP phosphodiesterase inhibitor, is a selective pulmonary vasodilator in chronically hypoxic pulmonary hypertensive rats].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Pressure; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Lung; Male; Phosphodiesterase Inhibitors; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilator Agents | 1998 |
[Chronic myeloproliferative diseases].
Topics: Chronic Disease; Female; Fibrinolytic Agents; Humans; Interferons; Leukemia, Myeloid; Male; Myeloproliferative Disorders; Polycythemia Vera; Primary Myelofibrosis; Quinazolines; Thrombocythemia, Essential | 1998 |
Electrophysiological effects of LU111995 on canine hearts: in vivo and in vitro studies.
Topics: Action Potentials; Animals; Antipsychotic Agents; Chronic Disease; Dogs; Electrocardiography; Electrophysiology; Female; Fumarates; Heart; Heart Block; Heart Rate; In Vitro Techniques; Male; Myocardial Contraction; Myocardium; Purkinje Fibers; Quinazolines; Refractory Period, Electrophysiological | 1999 |
Phosphodiesterase 5 inhibition restores impaired ACh relaxation in hypertensive conduit pulmonary arteries.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Acetylcholine; Animals; Chronic Disease; Cyclic Nucleotide Phosphodiesterases, Type 5; Dose-Response Relationship, Drug; Hypertension; Hypoxia; In Vitro Techniques; Male; Nitroprusside; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pulmonary Artery; Quinazolines; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 2001 |
[Effect and tolerance of Biarison (proquazone) in rheumatoid arthritis (author's transl)].
Topics: Adult; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chronic Disease; Humans; Middle Aged; Quinazolines | 1978 |
Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Time Factors; Vascular Resistance | 1979 |
Attenuation of prazosin effect on cardiac output in chronic heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Chronic Disease; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Stroke Volume; Vascular Resistance | 1979 |
Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance | 1979 |
Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
Topics: Adult; Aged; Chronic Disease; Ferricyanides; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Nitroprusside; Prazosin; Quinazolines | 1979 |
Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.
Topics: Acute Disease; Arteries; Cardiac Output; Chronic Disease; Electrocardiography; Forearm; Heart Failure; Heart Ventricles; Humans; Physical Exertion; Plethysmography; Prazosin; Pulmonary Edema; Quinazolines; Vasodilation; Veins | 1978 |
Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure.
Topics: Aged; Chronic Disease; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Prazosin; Quinazolines; Tachyphylaxis; Time Factors | 1979 |
Vasodilator therapy--a physiologic approach to the treatment of heart failure.
Topics: Administration, Oral; Advertising; Chronic Disease; Heart Failure; Hemodynamics; Humans; Prazosin; Quinazolines; Vasodilator Agents | 1977 |
Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodyn
Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Blood Pressure; Cardiac Output; Chronic Disease; Coronary Disease; Drug Evaluation; Dyspnea; Echocardiography; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Vascular Resistance; Vasodilator Agents | 1977 |
[The acute and chronic effects of bunazosin on exercise capacity estimated by the anaerobic threshold in patients with chronic congestive heart failure].
Topics: Adult; Aged; Anaerobic Threshold; Chronic Disease; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Middle Aged; Quinazolines | 1992 |
Hemodynamic and humoral effects of chronic antihypertensive treatment with fenquizone: importance of aldosterone response.
Topics: Adult; Aldosterone; Blood Pressure; Chronic Disease; Diuretics; Female; Forearm; Heart Rate; Hemodynamics; Humans; Hypertension; Male; Quinazolines; Regional Blood Flow; Renin; Sulfonamides; Vascular Resistance | 1990 |
[The use of deoxypeganin hydrochloride in the combined treatment of patients with diseases of the peripheral nervous system].
Topics: Adult; Alkaloids; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Muscle Tonus; Peripheral Nervous System Diseases; Quinazolines | 1989 |
[Acute and chronic effects of bunazosin in patients with congestive heart failure].
Topics: Adrenergic alpha-Antagonists; Atrial Natriuretic Factor; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinazolines | 1989 |
Hemodynamic benefits of long-term bunazosin (alpha-1 blocker) therapy in rats with myocardial infarction and heart failure.
Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cardiac Output, Low; Chronic Disease; Female; Heart Ventricles; Hemodynamics; Myocardial Infarction; Quinazolines; Rats; Rats, Inbred Strains; Vascular Resistance; Weight Gain | 1989 |
[Prazosin in the treatment of chronic cardiac insufficiency].
Topics: Adrenergic alpha-Antagonists; Arterioles; Cardiac Output; Chronic Disease; Heart Failure; Humans; Middle Aged; Prazosin; Pulmonary Wedge Pressure; Quinazolines; Time Factors; Veins | 1985 |
[Correlations between resting hemodynamics and exercise tolerance before and after prazosin therapy in patients with chronic congestive heart failure].
Topics: Adult; Aged; Chronic Disease; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prazosin; Quinazolines; Rest | 1985 |
Use of metolazone in the treatment of ascites due to liver disease.
Topics: Adult; Ascites; Chlorides; Chronic Disease; Diuretics; Female; Hepatic Encephalopathy; Humans; Hypokalemia; Hyponatremia; Ketones; Liver Diseases; Male; Middle Aged; Nitrogen; Pyrazines; Quinazolines; Spironolactone; Sulfonamides; Uremia | 1971 |